Evidence map›Paper›PMID 35893302›Full record

ArticleJournal of personalized medicine2022

MLP-PSO Hybrid Algorithm for Heart Disease Prediction.

Ali Al Bataineh, Sarah Manacek

Open access · goldAbstract read
In one paragraph

Article in Journal of personalized medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
35.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 142 citations in OpenAlex.

  1. Cross-cohort Generalization for Heart Disease Prediction with Explainable AI.Journal of cardiovascular translational research · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Ali Al BatainehDepartment of Electrical and Computer Engineering, Norwich University, Barre, VT 05663, USA.ORCID 0000-0001-9530-7950
Sarah ManacekDepartment of Nursing, College of Nursing and Health Sciences, The University of Vermont, Burlington, VT 05405, USA.ORCID 0000-0003-4251-0300
Norwich University · USUniversity of Vermont · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMachine Learning (ML) is becoming increasingly popular in healthcare, particularly for improving the timing and accuracy of diagnosis. ML can provide disease prediction by analyzing vast amounts of healthcare data, thereby, empowering patients and healthcare providers with information to make informed decisions about disease prevention. Due to the rising cost of treatment, one of the most important topics in clinical data analysis is the prediction and prevention of cardiovascular disease. It is difficult to manually calculate the chances of developing heart disease due to a myriad of contributing factors.

objectiveThe aim of this paper is to develop and compare various intelligent systems built with ML algorithms for predicting whether a person is likely to develop heart disease using the publicly available Cleveland Heart Disease dataset. This paper describes an alternative multilayer perceptron (MLP) training technique that utilizes a particle swarm optimization (PSO) algorithm for heart disease detection.

methodsThe proposed MLP-PSO hybrid algorithm and ten different ML algorithms are used in this study to predict heart disease. Various classification metrics are used to evaluate the performance of the algorithms.

resultsThe proposed MLP-PSO outperforms all other algorithms, obtaining an accuracy of 84.61%.

conclusionsAccording to our findings, the current MLP-PSO classifier enables practitioners to diagnose heart disease earlier, more accurately, and more effectively.

Indexed as

heart disease predictionmachine learningMLPneural networksPSO

Identifiers

PMID35893302
PMCPMC9394266
OpenAlexW4287833982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.